Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-08

Clinical Trial Update: Yerba Mate (Ilex Paraguariensis A.St.-Hil.): Assessment of Cardiovascular Health [NA]

View source ↗

Summary

A completed clinical trial evaluating Yerba Mate (Ilex paraguariensis) for cardiovascular health has finished.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Yerba Mate (Ilex paraguariensis)

Snippet

Sponsor: Karimi Sater Gebara | Conditions: Cardiovascular Disease, Diabetes | NA | Status: COMPLETED